Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
16.9 USD | +3.97% | +20.34% | +62.07% |
03:49pm | Piper Sandler Adjusts Price Target on Teva Pharmaceutical Industries to $20 From $19, Maintains Overweight Rating | MT |
08/05 | Sector Update: Health Care Stocks Slipping Wednesday Afternoon | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+62.07% | 18.41B | |
+30.11% | 684B | |
+30.34% | 568B | |
-3.81% | 361B | |
+18.10% | 329B | |
+4.14% | 284B | |
+16.21% | 240B | |
+9.66% | 208B | |
-6.83% | 200B | |
+7.09% | 166B |
- Stock Market
- Equities
- TEVA Stock
- News Teva Pharmaceutical Industries Limited
- Teva Pharmaceutical Unit Secures US Approval for Generic Version of Forteo